Makoto Hasegawa, Yasuhiro Osugi, Yoshifumi Moriwaki, Yohei Doi
{"title":"日本长期护理机构中尿路感染的回顾性分析:基于体格检查诊断的启示。","authors":"Makoto Hasegawa, Yasuhiro Osugi, Yoshifumi Moriwaki, Yohei Doi","doi":"10.20407/fmj.2023-012","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Multidrug-resistant (MDR) bacterial infections are highly prevalent among long-term care facility (LTCF) residents, and are thus important targets for antimicrobial stewardship. Diagnoses of urinary tract infections (UTIs), which are associated with antimicrobial use in these facilities, are not always made by physicians. Past epidemiologic studies have included asymptomatic bacteriuria together with UTIs. The National Healthcare Safety Network has initiated a surveillance program to identify the causative organisms of UTIs in LTCF residents. In Japan, medical care for these residents is provided through in-person physician visits; however, limited related data are available. Therefore, we investigated the organisms causing UTIs and their drug susceptibility among LTCF residents in central Japan, and examined the prevalence of multidrug resistance, its risk factors, and correlations with clinical outcomes.</p><p><strong>Methods: </strong>We retrospectively evaluated clinical and urine culture data of LTCF residents with physician-diagnosed UTIs between April 1, 2019, and April 30, 2022.</p><p><strong>Results: </strong>The detection rate of multidrug-resistant organisms was high, with <i>Escherichia coli</i> being the most prevalent. Ceftriaxone was frequently used for initial therapy. The initial antimicrobial agents were significantly less active against MDR pathogens than non-MDR pathogens. Most residents continued to receive the initial agents regardless of culture results. Nonetheless, differences in the therapy duration, relapse and hospitalization rates, and death rate within 28 days between the multidrug-resistant and non-multidrug-resistant groups were not significant.</p><p><strong>Conclusions: </strong>Antimicrobial stewardship is essential for reducing antimicrobial use and selective pressure in LTCFs in Japan; however, more specific data are needed for its effective implementation.</p>","PeriodicalId":33657,"journal":{"name":"Fujita Medical Journal","volume":"10 1","pages":"24-29"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10847634/pdf/","citationCount":"0","resultStr":"{\"title\":\"Retrospective analysis of urinary tract infections in long-term care facilities in Japan: Insights from physical examination-based diagnosis.\",\"authors\":\"Makoto Hasegawa, Yasuhiro Osugi, Yoshifumi Moriwaki, Yohei Doi\",\"doi\":\"10.20407/fmj.2023-012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Multidrug-resistant (MDR) bacterial infections are highly prevalent among long-term care facility (LTCF) residents, and are thus important targets for antimicrobial stewardship. Diagnoses of urinary tract infections (UTIs), which are associated with antimicrobial use in these facilities, are not always made by physicians. Past epidemiologic studies have included asymptomatic bacteriuria together with UTIs. The National Healthcare Safety Network has initiated a surveillance program to identify the causative organisms of UTIs in LTCF residents. In Japan, medical care for these residents is provided through in-person physician visits; however, limited related data are available. Therefore, we investigated the organisms causing UTIs and their drug susceptibility among LTCF residents in central Japan, and examined the prevalence of multidrug resistance, its risk factors, and correlations with clinical outcomes.</p><p><strong>Methods: </strong>We retrospectively evaluated clinical and urine culture data of LTCF residents with physician-diagnosed UTIs between April 1, 2019, and April 30, 2022.</p><p><strong>Results: </strong>The detection rate of multidrug-resistant organisms was high, with <i>Escherichia coli</i> being the most prevalent. Ceftriaxone was frequently used for initial therapy. The initial antimicrobial agents were significantly less active against MDR pathogens than non-MDR pathogens. Most residents continued to receive the initial agents regardless of culture results. Nonetheless, differences in the therapy duration, relapse and hospitalization rates, and death rate within 28 days between the multidrug-resistant and non-multidrug-resistant groups were not significant.</p><p><strong>Conclusions: </strong>Antimicrobial stewardship is essential for reducing antimicrobial use and selective pressure in LTCFs in Japan; however, more specific data are needed for its effective implementation.</p>\",\"PeriodicalId\":33657,\"journal\":{\"name\":\"Fujita Medical Journal\",\"volume\":\"10 1\",\"pages\":\"24-29\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10847634/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fujita Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20407/fmj.2023-012\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/11/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fujita Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20407/fmj.2023-012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:耐多药(MDR)细菌感染在长期护理机构(LTCF)居民中非常普遍,因此也是抗菌药物管理的重要目标。泌尿道感染(UTI)与这些机构中抗菌药物的使用有关,但并非总是由医生做出诊断。过去的流行病学研究将无症状菌尿与尿路感染一并纳入研究范围。美国国家医疗保健安全网络(National Healthcare Safety Network)已经启动了一项监测计划,以确定长者照护中心居民尿毒症的致病菌。在日本,对这些居民的医疗护理是通过医生上门提供的,但相关数据却很有限。因此,我们调查了日本中部地区 LTCF 居民中引起 UTI 的病原菌及其对药物的敏感性,并研究了多重耐药性的发生率、其风险因素以及与临床结果的相关性:我们回顾性评估了2019年4月1日至2022年4月30日期间由医生诊断为UTI的LTCF住院患者的临床和尿培养数据:结果:多重耐药菌的检出率很高,其中以大肠埃希菌最为普遍。头孢曲松常用于初始治疗。初始抗菌药物对耐多药病原体的活性明显低于非耐多药病原体。无论培养结果如何,大多数住院患者都会继续接受初始药物治疗。然而,耐多药组和非耐多药组在治疗持续时间、复发率和住院率以及28天内死亡率方面的差异并不显著:抗菌药物管理对于减少日本 LTCF 中抗菌药物的使用和选择性压力至关重要;但是,要有效实施抗菌药物管理,还需要更多具体数据。
Retrospective analysis of urinary tract infections in long-term care facilities in Japan: Insights from physical examination-based diagnosis.
Objectives: Multidrug-resistant (MDR) bacterial infections are highly prevalent among long-term care facility (LTCF) residents, and are thus important targets for antimicrobial stewardship. Diagnoses of urinary tract infections (UTIs), which are associated with antimicrobial use in these facilities, are not always made by physicians. Past epidemiologic studies have included asymptomatic bacteriuria together with UTIs. The National Healthcare Safety Network has initiated a surveillance program to identify the causative organisms of UTIs in LTCF residents. In Japan, medical care for these residents is provided through in-person physician visits; however, limited related data are available. Therefore, we investigated the organisms causing UTIs and their drug susceptibility among LTCF residents in central Japan, and examined the prevalence of multidrug resistance, its risk factors, and correlations with clinical outcomes.
Methods: We retrospectively evaluated clinical and urine culture data of LTCF residents with physician-diagnosed UTIs between April 1, 2019, and April 30, 2022.
Results: The detection rate of multidrug-resistant organisms was high, with Escherichia coli being the most prevalent. Ceftriaxone was frequently used for initial therapy. The initial antimicrobial agents were significantly less active against MDR pathogens than non-MDR pathogens. Most residents continued to receive the initial agents regardless of culture results. Nonetheless, differences in the therapy duration, relapse and hospitalization rates, and death rate within 28 days between the multidrug-resistant and non-multidrug-resistant groups were not significant.
Conclusions: Antimicrobial stewardship is essential for reducing antimicrobial use and selective pressure in LTCFs in Japan; however, more specific data are needed for its effective implementation.